Provided by Tiger Trade Technology Pte. Ltd.

Fractional Shares

1,978.20
-8.2064-0.41%
Number of Gainers:304
Number of Losers:689
Number of Flat:28
PE:- -
High:1,996.99
Open:1,986.55
Low:1,966.37
Close:1,986.41
Volume:5.67B
Turnover:697.91B
Market Cap:94.62T
Float Cap:88.49T

Loading ...

Longevity Health Enters Securities Purchase Deal with Puritan Partners for up to $625,000 in Senior Secured Convertible Notes

Reuters
·
Sep 08

Trade Desk Announces Special Shareholder Meeting

Reuters
·
Sep 08

Axcelis Technologies, - to Invest $35 Mln in New Manufacturing Facility in Pyeongtaek, Korea

THOMSON REUTERS
·
Sep 08

Aduro Clean Tech to Present Hydrochemolytic Technology at Chemical Recycling Europe Annual Conference

Reuters
·
Sep 08

Nearly 2 Trillion Yuan Traded in A-Shares Today as Oil and Gas Sector Jumps 3.68%

Deep News
·
Sep 08

Transforming Resource Riches into Industrial Strength: Liangshan Charts a Bold Path for the 15th Five-Year Plan

Deep News
·
Sep 08

Samsung Leads Mistral AI's €3 Billion Funding Round

Deep News
·
Sep 08

30GWh Deal? Samsung SDI in Talks to Supply Energy Storage Batteries to a Major BESS Integrator

Deep News
·
Sep 08

Charles River Expands Endosafe Cartridge Output with Automated Manufacturing Suite

Reuters
·
Sep 08

Wells Fargo CFO Santomassimo Presents at Barclays Global Financial Services Conference

Reuters
·
Sep 08

Abbott Receives FDA Approval for Its Tactiflex™ Duo Ablation Catheter to Treat People with Abnormal Heart Rhythms

THOMSON REUTERS
·
Sep 08

Abbott - to Begin Broader Commercial Adoption of Tactiflex Duo in U.S. in Coming Weeks

THOMSON REUTERS
·
Sep 08

General Mills Reaffirms Annual Guidance and Provides Business Update at 2026 Barclays Global Consumer Staples Conference

THOMSON REUTERS
·
Sep 08

General Mills - Reaffirms Full-Year Financial Outlook for Fiscal 2027

THOMSON REUTERS
·
Sep 08

Intellia Therapeutics, - FDA Accepts Bla for Lonvo-Z and Grants Priority Review with Pdufa Date March 10, 2027

THOMSON REUTERS
·
Sep 08

Intellia Therapeutics Announces FDA Acceptance of Biologics License Application with Priority Review for Lonvoguran Ziclumeran (Lonvo-Z) for Hereditary Angioedema (Hae)

THOMSON REUTERS
·
Sep 08

Intellia Therapeutics, - FDA not Planning to Hold Advisory Committee for Lonvo-Z Application

THOMSON REUTERS
·
Sep 08

GE Healthcare Aims to Advance a New Era in Theranostics with Starguide™ Gx 4D Spect/Ct, NOW 510(k) Pending with the U.S. FDA

THOMSON REUTERS
·
Sep 08

Agilent Announces Retirement of Board Chair Koh Boon Hwee, Appointment of Glenn Boehnlein to Board of Directors

THOMSON REUTERS
·
Sep 08

Breakingviews-Honda’s Cost Cuts Can Restore Its Mediocrity

Reuters
·
Sep 08